Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis.

[1]  Won-Il Choi,et al.  Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis. , 2013, American journal of respiratory and critical care medicine.

[2]  Rui-Hua Jiang,et al.  Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study. , 2013, International journal of antimicrobial agents.

[3]  Jae Ho Lee,et al.  Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes , 2011, The Korean journal of internal medicine.

[4]  J. Alffenaar,et al.  Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Brendan Prideaux,et al.  High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. , 2011, Analytical chemistry.

[6]  D. Li,et al.  High performance liquid chromatography assay with ultraviolet detection for moxifloxacin: validation and application to a pharmacokinetic study in Chinese volunteers. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  B. Greijdanus,et al.  Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method. , 2010, Journal of analytical toxicology.

[8]  K. Colpaert,et al.  Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  J. Pitt,et al.  Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry. , 2009, The Clinical biochemist. Reviews.

[10]  John L. Johnson,et al.  Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis , 2007, Antimicrobial Agents and Chemotherapy.

[11]  M. Jelikiċ-Stankov,et al.  Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  J. Yim,et al.  Cost of treatment for multidrug‐resistant tuberculosis in South Korea , 2006, Respirology.

[13]  S. Siewert.  Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. , 2006, Journal of pharmaceutical and biomedical analysis.

[14]  G. Ramachandran,et al.  Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  C. Leung,et al.  Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong. , 2003, Chest.

[16]  B. Matuszewski,et al.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.

[17]  Charles L Daley,et al.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. , 2003, American journal of respiratory and critical care medicine.

[18]  G. Shabir,et al.  Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. , 2003, Journal of chromatography. A.

[19]  M. Bartlett,et al.  Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry. , 2002, Journal of pharmaceutical and biomedical analysis.

[20]  J. Velly,et al.  Determination of moxifloxacin (BAY 12-8039) in plasma and lung tissue by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric cartridge. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[21]  S. Berning.  The Role of Fluoroquinolones in Tuberculosis Today , 2012, Drugs.